AllPennyStocks.com Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
This Microcap Just Pulled Core From One of Copper's Last Frontiers
Target Expansion and Geophysics Survey Trigger 18% Surge for Norwegian Base-Metal Project
Most Popular
{{ index + 1 }}


Back to Top